Introduction
Study of therapeutic protein products, especially monoclonal antibodies (mAbs), has recently attracted a great deal of attention from pharmaceutical industries. In the last 20 years, over 20 mAbs have been approved in various therapeutic categories and hundreds of mAbs are currently in various stages of development. 1 Six antibody pharmaceuticals including Humira (adalimumab) and Remicade (infliximab) retain the top two market positions of pharmaceuticals in 2012. 2 These biopharmaceutical products have been drastically improving the quality of life of patients.
Antibodies have been studied for over a century, and the basic structures and functions are now well understood. [3] [4] [5] Antibodies consist of two pairs of the light and heavy polypeptide chains that are held together through disulfide bridges. Light chains have two isotypes, λ and κ, which differ from each other in the sequence composition. Heavy chains are classified into five isotypes based on the chain structure and the effector function. All therapeutic mAbs approved currently belong to the immunoglobulin G (IgG) class. IgG has the simplest form among antibodies and is the major immunoglobulin type in human sera. IgGs are further divided into four subclasses, IgG1, IgG2, IgG3 and IgG4. The sequences of the light chain and the N-terminal domain of the heavy chains (called Fab domain) are variable, while the remaining domain is conserved. The variable domain, especially the complementarity determining region (CDR), determines the antigen binding specificity. Each IgG subclass has a characteristic disulfide bonding pattern, which differs mostly in the hinge region. 6, 7 Compared to small pharmaceutical molecules, therapeutic protein products such as mAbs are considerably large entities with inherent physicochemical complexity. Therefore, many physical and chemical characteristics may have significant relations to protein degradation and consequently affect the quality of therapeutic protein products during manufacturing, storage, shipping, and handling steps. [8] [9] [10] Chemical degradation of proteins involves fragmentation, oxidation (mostly occurring at methionine and tryptophan residues), deamidation (mostly occurring at asparagine residues), and disulfide scrambling. Physical degradation of proteins involves unfolding, dissociation, denaturation, adsorption, precipitation processes, and aggregate formations. 10 Aggregates are one of the most hazardous protein impurities of therapeutics because of the high risk of immune response or immunogenicity. degradation pathways by evaluating the characteristics of the biopharmaceutical products prior to the stability tests. The typical measures are the melting temperature (Tm) and the standard enthalpy of the melting point (ΔmH ) of the variable domains assessed by differential scanning calorimetry (DSC). Since it has been considered that the increase in Tm results in the suppression of the aggregate formation and the denaturation, several trials including solvent selection are reported to increase Tm of each antibody domain, especially of the Fab domain. 16, 17 Fluorescence spectroscopy with extrinsic fluorescent probe dyes such as 1-anilinonaphthalene-8-sulfonate (ANS), 4,4′-bis-1-anilinonaphthalene-8-sulfonate (bis-ANS), Nile Red, and Congo Red can also be employed as a highly sensitive method for protein characterization.
Non-covalent hydrophobic or electrostatic interactions of the extrinsic dyes with proteins and protein degradation products are utilized for the characterization of pharmaceutical formulations. 18 Semisotnov et al. revealed a strong affinity of ANS to the solvated hydrophobic core of molten globular intermediates of carbonic anhydrase B and α-lactalbumins. 19 The wavelength (λmax) and the intensity (Fint) of the maximum fluorescence peak of the noncovalently bound extrinsic fluorescent dyes may be utilized as measures for protein characterization in screening tests in early stages of formulation development and in selection of formulation buffer suitable for biopharmaceutical products.
In formulation development, samples are dissolved in various kinds of solutions for DSC and fluorescence spectral tests with dyes. However, the observed DSC and spectral parameters are affected not only by intrinsic conformational change of proteins but by solvent-related changes. Therefore, DSC and fluorescence spectral tests should be performed with a given common solution. However, there are only a few papers dealing with these parameters evaluated in a common solution for comprehensive assessment and prediction of mAbs aggregation. 20, 21 Recently, assessment and prediction of protein aggregation by computational approaches have attracted attention. For example, Wang et al. attempted to predict the susceptibility to the aggregation of commercial antibodies based on the information on the amino acid sequences and the Fab structures of potential aggregation-prone regions (APR) by using sequence-based computational tools. 22 This proposal is quite innovative because aggregation risk of each antibody can be predicted only from its amino acid sequence. However, in this study, we confirmed that some antibodies with few aggregation prone regions easily aggregated under heat-stressed conditions. It thus appears to be risky to predict the tendency of the aggregation based on the information alone from the amino acid sequence of APR. Therefore, the combinational utilization of the sequence information and physical properties evaluated experimentally is important for more appropriate prediction of the aggregation propensity of proteins.
In this study, we used eight kinds of IgG1 antibodies as model protein pharmaceuticals, and five physicochemical parameters experimentally evaluated and two physicochemical parameters calculated based on the information from the amino acid sequence, as explanatory valuables to be related to the aggregate formation. The experimental parameters used were: Tm as an index parameter of the structural stability of the antibody and ΔmH representing the energy required for the structural change evaluated by DSC, λmax and Fint evaluated by fluorescent spectroscopy with ANS, since it is known that the blue shift and intensification of the ANS fluorescence are associated with its binding to a hydrophobic core of proteins 19 ; and the z-average diameter (D) evaluated from the particle size by dynamic light scattering (DLS). The calculated parameters used were: the isoelectric point (pI) and the hydrophobicity of the CDR (Hpho) evaluated from the amino acid sequence of the antibody sample, since it has been reported that these parameters are strongly related with the formation of the protein aggregation. [23] [24] [25] The heat-stressed samples of the target antibodies were prepared and the soluble and insoluble aggregation formations were assessed by size exclusion chromatography (SE-HPLC). The aggregation formation data were correlated to the experimental and the calculated parameters. Multivariate analysis was done based on Akaike's information criterion (AIC) 26, 27 to pick out the important explanatory parameters to characterize the aggregate formation. In this paper, we also discuss the mechanism and the potent approach to suppress the soluble and insoluble aggregate formation of IgG.
Experimental

Chemicals and reagents
The pure standard samples of six recombinant human mAbs (IgG1) were obtained from Kyowa Hakko Kirin (Tokyo, Japan). These antibodies were expressed in Chinese Hamster Ovary cells, cultured and purified by using a series of chromatographic and filtration steps. Synagis injection containing Palivizumab and Rituxan containing Rituximab were purchased from Abbvie (North Chicago, IL) and F. Hoffmann-La Roche (Basel, Schweiz), respectively. All antibody samples were reconstituted with phosphate buffer saline (PBS; 10 mM Na2HPO4, 1.76 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4; M = mol dm -3 ) and named randomly as mAb A to H. Heat-induced mAbs aggregate-containing samples were prepared by heat-induction of the native mAbs at 50 C for typically one week, two weeks and one month. Other chemical reagents were of analytical reagent grade.
Size-exclusion chromatography
Size-exclusion chromatography (SE-HPLC) was performed with an Agilent 1100 chromatography system connected to a Tosoh TSKgel G3000SWXL (300 × 7.8 mm, 5-μm particle size). The mobile phase was 50 mM NaH2PO4/Na2HPO4 (pH 7) containing 500 mM NaCl. The flow ratio was 1.0 mL/min and the column temperature was set at 25 C. The injection amount of samples and the method run time were set at 20 μg and 20 min, respectively.
Differential scanning calorimetry
The thermal stability of individual domains was evaluated by differential scanning calorimetry (DSC). Measurements were performed on a 1.0 mg/mL IgG solution using a capillary VP-DSC system (MicroCal LLC, Northampton, MA) with a cell volume of 0.135 mL. The temperature scan was performed from 5 to 100 C at a scan rate of 1 C/min. A buffer-buffer reference scan was subtracted from the corresponding sample scan before the concentration normalization. Baselines were created with Origin 7.0 (OriginLab, Northampton, MA) by cubic interpolation of the pre-and post-transition baselines.
Fluorescence probe spectrometry
Fluorescence measurements were performed on a Tecan Infinite 200 plate reader at an excitation wavelength of 380 nm. Emission intensity was collected in the range of 400 -600 nm. The excitation bandwidth and the emission bandwidth were set as 9 and 20 nm, respectively. Measurements were performed at 25 C. The samples were diluted by PBS containing ANS at 0.3 mg/mL (100 μM as the final concentration) and injected 100 μL each to the 96-well black plate /clear bottom.
Dynamic light scattering
Dynamic light scattering (DLS) analysis was performed on a DynaPro TM plate reader system equipped with an 832-nm laser using a 384-well bottom-read plate (Wyatt, Santa Barbara, CA). Measurements were performed at 25 C. Each well contained 30 μL of a sample solution at a protein concentration of 10 mg/mL. The scattering data were fit (Dynamics software; Wyatt) assuming Rayleigh sphere scattering.
Results and Discussion
Physicochemical experimental characteristics of the antibodies
The antibody samples investigated here were characterized in terms of the conformational stability, the surface hydrophobicity, and the molecular size by DSC, fluorescence assay with ANS, and DLS, respectively. Figure 1 shows the DSC scanning patterns of the native antibody samples. The antibody sample solutions exhibited typical profiles with two or three transitions in the temperature range from 60 to 90 C. The largest endothermic peak in each sample corresponds very likely to the thermal transition of the Fab domain as judged from the observed temperature and the magnitude of the peak, based on the literature. [28] [29] [30] Since the structural stability of the Fab domain makes a significant contribution to the structural stability of the antibody, 20, 21, 29 we focused first on Tm of the Fab domain as an index parameter of the structural stability of the antibody. The data are summarized in Table 1 . Tm of the Fab domain of mAb B was 67.3 C, which was the lowest among the eight antibodies. On the other hand, mAb E showed the highest Tm of the Fab domain (90.3 C).
In addition, ΔmH representing the energy required for the structural change is another index parameter of the structural stability. It is generally considered that an antibody with large ΔmH has the structural stability. 29 The evaluated ΔmH values are also summarized in Table 1 . Among the samples, mAb B showed the lowest ΔmH , while mAb E showed the highest value. The tendency is well correlated to that of Tm of the Fab domain.
Fluorescence spectra of ANS in the presence of the native antibody are given in Fig. 2 . A significant blue shift and intensification of the fluorescence maximum peak are observed for mAb G, as compared with other antibodies. It is known that the blue shift of the ANS fluorescence is associated with its binding to a hydrophobic core of proteins. 19 Hence most likely, mAb G has significant hydrophobic regions on the protein surface compared with other mAbs. The antibody mAb B also shows a slight blue shift and intensification of the fluorescence maximum. On the other hand, no significant change was observed for other antibodies. The λmax and Fint values are summarized in Table 1 . The DLS distribution patterns of the native antibody are given in Fig. 3 . The D value was calculated from the particle size by using the Stokes-Einstein equation on the assumption that each molecule is in sphere. Any antibody used here has the same amino-acid sequence except the CDR with a similar molecular mass of about 150 kDa. However, as summarized in Table 1 , it has been revealed that each antibody has a characteristic D value. Among them, mAb H gave the smallest D value, and mAb F gave the largest one.
Furthermore, the pI value of CDR was calculated from the amino acid sequence according to a method proposed by Henriksson G et al. 31 The data are also summarized in Table 1 . The CDR of mAb B gave a rather small value of pI (4.48) compared with the other antibodies. On the other hand, pI of CDR of mAb D, E, F, and G were located in a narrow region from 9 to 9.6. In addition, the hydrophobicity of the CDR was also calculated from the amino acid sequence according to the method proposed by Kyte et al. 32 The data summarized in Table 1 show that the CDR of mAb B is the most hydrophobic, and that of mAb H is the most hydrophilic among the eight antibodies examined. Figure 4 shows the SE-HPLC chromatograms of native and heat-induced aggregate-containing samples of mAb B and mAb G. In the case of mAb B (Panel A), the main peak of the monomer (at a retention time of about 7.8 min) decreased in height and the broad peaks (at retention times of 5 -5.5 min) assigned to soluble aggregates increased with an increase in the heat-treatment time. The small peak at 6.7 min is assigned to a dimer, and the peak area remains almost constant. By considering the time dependence of the peak area, the monomer is gradually denaturated in part during the heat-treatment to form multimeric and soluble aggregates via the dimeric aggregate. In the case of mAb G (panel B), the main peak of the monomer decreased with the heat-treatment time, but the broad peaks assigned to the soluble aggregates remained small. Therefore, the decrease in the main peak is mainly attributed to the formation of the insoluble aggregates, which could not be detected on the present SE-HPLC.
Soluble and insoluble aggregate formation in the heat-induced antibody samples
In this study, we will define a ratio of soluble aggregates (As) by
where Ps is the peak area of the broad soluble aggregates of the heat-treatment samples, and Pn is the total area of all peaks of the native one. We also define a ratio of insoluble aggregates (Ai) by
where Ph is the total area of all peaks of heat-treatment samples. Some mAbs gave negative Ai as in the case of mAb B. This seems to be ascribed to the slight concentration of the test sample during the long time heat-treatment at 50 C due to the evaporation. Therefore, we corrected each Ai value by Ai values of mAb B as the solvent evaporation control. Since the volumes of all test samples at a given time were identical with each other, the concentration effect gives an identical bias on Ai of all of the samples. Figure 5 shows time dependence of As and Ai of mAb B and mAb G. Given linear dependence of As and Ai against the heat-treatment time, we also evaluated the slope of dAs/dt and dAi/dt as kinetic indexes (rate constants) of the soluble and insoluble aggregate formation, respectively, where t is the storage time of heat-treatment samples. The data are summarized in Table 2 . The antibody mAb B gave a significantly large value of dAs/dt, indicating that mAb B is labile to form soluble aggregates during the heat-treatment at 50 C. On the other hand, mAb G gave a large dAi/dt, indicating that mAb G is labile to form insoluble aggregates. Indeed, clear precipitates were observed in heat-induced aggregate-containing mAb G samples after 2-week or 1-month treatments at 50 C (data not shown). Table 3 summarizes correlation coefficients between the physicochemical parameters (Tm, ΔmH , λmax, Fint, D, pI, and Hpho) and between each of the physicochemical parameters and each of the aggregation kinetic parameters (dAs/dt and dAi/dt). Strong correlations are recognized between Tm and ΔmH evaluated from DSC, and between λmax and Fint evaluated by fluorescence probe spectroscopy. It seems to be reasonable to consider that an antibody with a high Tm is thermo-stable and then gives a large ΔmH . It also seems to be reasonable to consider that the interaction of ANS with hydrophobic binding sites within proteins is accompanied by both an increase in fluorescence intensity and a blue shift of the peak maximum.
Statistical analysis and discussion
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Strong correlation is also observed between D and the calculated pI of CDR. The fact suggests that since all mAbs have molecular mass of about 150 kDa, the net charge of the CDR may affect the higher-order structure such as the angle of the hinge. The CDR is the antigen-recognizing site and thus locates on the surface of the antibody. The D value may change, when the angle of the hinge is changed by the electrostatic repulsive or attractive force between the CDR and the domains except for the CDR due to the charge of the CDR.
For the aggregation parameters, dAi/dt is strongly related to Fint, but the correlations between dAi/dt and each of the other physicochemical parameters, and between dAs/dt and each of the physicochemical parameters are not so strong. Thus, we conducted multivariate analysis between the physicochemical characters as the explanatory variables and the aggregation parameters as the response variables by using Akaike's information criterion (AIC). 26, 27 The parameters ΔmH , λmax, and D were excluded from the explanatory variables, because those are strongly correlated with Tm, Fint, and pI, respectively, and the scattering of the values of Tm, Fint, and pI is larger than that of ΔmH , λmax, and D. Therefore, the physicochemical parameters used as the explanatory variables are: Tm, Fint, pI, and Hpho to correlate with the response variable dAs/dt and dAi/dt. The AIC is defined by AIC = NIn S + 2K (3) where N, K, and S are the number of data, the number of explanatory variables, and the residual sum of the squares, respectively. When there are several competing models, the fitting model that gives the minimum AIC is considered the one with statistically maximum likelihood. As shown in Table 4 , the best expression for dAs/dt is:
dAs/dt = -0.0819 pI -0.0203 Tm + 2.67 (R = 0.801)
The correlation between the observed and the calculated ones is given in Fig. 6 , panel A. This regression equation means that antibodies with low pI and Tm are labile to form soluble aggregates. Since an antibody with low pI has negatively charged CDR at neutral pH, the electrostatic interaction between the negatively charged CDR and other positively charged region may lead to the formation of soluble aggregates. Furthermore, the calculated pI values of the whole antibody (mAb A to H) are from 9.0 to 9.4, so there are many positively charged regions in the antibodies at neutral pH. In case that there exist some positively charged materials as ultra-trace impurities in solutions, the positively charged materials such as metal ion may mediate the formation of soluble aggregates. There are several reports of metal ion-mediated aggregate formation. 34, 35 In addition, since Tm represents the thermo-stability of Fab, an antibody with high Tm may have resistance to the thermal denaturation, which leads to the soluble aggregate formation. On the other hand, the best expression for dAi/dt is (see Table 4 
The correlation between the observed and the calculated ones is given in Fig. 6 , panel B. This regression equation means that antibodies with large Fint and high pI are labile to form insoluble aggregates. The situation may lead to insoluble aggregate formation. Large Fint value means that the protein has rather large hydrophobic region (or core). Since an antibody with high pI of CDR has positively charged CDR and other regions at neutral pH, a repulsive force should be generated between each antibody molecule. However, in the case that mAbs come into contact with some negatively charged materials, the negatively charged materials such as Teflon may mediate the formation of insoluble aggregates. These materials are often used as membranes or containers and it is difficult to completely prevent contact with mAbs. The aggregate formation pathway is generally considered as: "native"  "denatured" → soluble aggregates → "insoluble aggregate". This means that a reversible structural change from the native to a denatured form(s) triggers the soluble aggregate formation, and the insoluble aggregation is mediated by soluble aggregate formation. 23 Since antibodies with "low" pI and Tm are labile to form soluble aggregates and antibodies with large Fint and "high" pI are labile to form insoluble aggregates, this study shows that the explanatory variables strongly correlated with dAs/dt are different from those correlated with dAi/dt. Therefore, at least, the rate determining step of the soluble aggregate formation is different from that of the insoluble aggregate formation. In the soluble aggregate formation, an electrostatic interaction seems to be a predominant one as the driving force and the kinetic barrier is reflected by the thermo-stability as expressed by Tm (or ΔmH ). On the other hand, the critical parameter of the insoluble aggregate formation seems to be the formation of the hydrophobic core, and when the hydrophobic core mediates the aggregate formation, the insoluble aggregates may be formed predominantly. These discussions indicate that an approach to prevent the soluble aggregate formation should be different from that to prevent the insoluble aggregate formation. The stabilization of native antibody may be the key factor to prevent soluble aggregates and the minimization of the hydrophobic core formation may be the key factor to prevent insoluble aggregates. It would be effective for the prevention of soluble aggregates formation to find an appropriate pH of the solution, which increases Tm of the target antibody. On the other hand, it would be effective for the prevention of insoluble aggregates formation to add some detergents to hide the hydrophobic core. Since antibodies with low or high pI are labile to form soluble or insoluble aggregates, respectively, it may also be effective to set the appropriate salt concentration of the solution for suppression of the soluble and insoluble aggregate formation. In addition, substitution with some charged amino acids to shift the pI of the CDR close to the neutral pH may be effective to suppress soluble and insoluble aggregate formation. Some reports also indicate that amino acid substitution would increase the binding affinity between antigen and antibody.
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Conclusions
As for antibodies in the same class, an amino acid sequence of more than 90% is stored in the primary structure, and the difference in the amino acid composition is almost limited in the CDR. However, the difference causes the difference in the electrostatic and hydrophobic interactions, which leads to a large variance in thermo-stability, the higher-order structure, and the z-average diameter. It is reconfirmed that these differences contribute to the difference in the soluble and insoluble aggregate formation. We have also confirmed that the soluble aggregate formation induced by heat stress is correlated to the thermo-stability of the Fab domain and "low" pI of the CDR, and the insoluble aggregate formation is correlated with the hydrophobic core (higher-order structure) of the antibody and "high" pI of the CDR. These results suggest that the rate-determining step, or more strongly, the pathways of the soluble and the insoluble aggregate formations are different from each other, and that the prediction of the risk of the soluble and insoluble aggregate formation of antibody seems to be possible. Since the present approach to predict the aggregation formation has acceptable reliability and requires only a small amount of test sample in a short time, it would be very useful for selecting an appropriate cell to express a target antibody with high resistance to the aggregate formation from a large variety of candidates.
